Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$1.43
$0.169913.48%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 76.83M | 63.77M | 61.01M | 77.00M | 75.01M |
| Total Depreciation and Amortization | 14.43M | 14.42M | 12.79M | 13.53M | 12.85M |
| Total Amortization of Deferred Charges | 885.70K | 885.70K | 885.70K | 409.20K | 409.20K |
| Total Other Non-Cash Items | 53.15M | 36.00M | 25.10M | 18.51M | 22.13M |
| Change in Net Operating Assets | -43.27M | -11.65M | 28.11M | -10.63M | -30.32M |
| Cash from Operations | 102.03M | 103.43M | 127.90M | 98.83M | 80.08M |
| Capital Expenditure | -10.29M | -11.94M | -13.39M | -17.13M | -18.97M |
| Sale of Property, Plant, and Equipment | 636.00K | 769.80K | 743.40K | -1.01M | 1.36M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.15M | -4.83M | -4.38M | 1.21M | -2.33M |
| Cash from Investing | -21.80M | -15.99M | -17.02M | -16.93M | -19.94M |
| Total Debt Issued | 4.05B | 5.59B | 5.49B | 7.53B | 7.35B |
| Total Debt Repaid | -4.01B | -5.42B | -5.62B | -6.19B | -6.46B |
| Issuance of Common Stock | 1.86B | 1.79B | 1.79B | 516.44M | 471.15M |
| Repurchase of Common Stock | -1.89B | -1.96B | -1.95B | -665.98M | -892.80M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -45.73M | -44.64M | -33.34M | -41.92M | -30.57M |
| Other Financing Activities | -820.09M | -822.85M | -811.57M | -1.14B | -907.72M |
| Cash from Financing | -92.62M | -91.66M | -94.37M | -41.53M | -54.13M |
| Foreign Exchange rate Adjustments | 4.79M | -430.40K | -4.19M | -13.68M | -12.63M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.60M | -4.66M | 12.32M | 26.70M | -6.61M |
